非酒精性脂肪肝
基因敲除
安普克
油红O
脂肪肝
脂肪变性
岩石1
脂质代谢
生物
癌症研究
化学
内分泌学
内科学
医学
疾病
细胞生物学
生物化学
脂肪组织
蛋白激酶A
磷酸化
基因
脂肪生成
作者
Xi Chen,Xinrui Tan,Shijun Li,Xingxing Zhang
出处
期刊:Life Sciences
[Elsevier]
日期:2019-10-01
卷期号:235: 116829-116829
被引量:71
标识
DOI:10.1016/j.lfs.2019.116829
摘要
Nonalcoholic fatty liver disease (NAFLD) is a severe liver disease, which influences the health of people worldwide. However, the specific mechanism of the disease remains unknown, and effective treatments are still lacking. It was reported that Nuclear enriched abundant transcript 1 (NEAT1) obviously was up-regulated in NAFLD model. But the role and underlying mechanism of NEAT1 in NAFLD is unclear. HepG2 cells were treated by free fatty acids (FFA) and C57BL/6J mice were treated by high-fat diet to establish NAFLD in vitro and in vivo models, respectively. Cell transfection was applied to regulate the expression of NEAT1, ROCK1, and miR-146a-5p. Western blotting and qRT-PCR were used for measuring expression of protein and mRNA level, respectively. Dual luciferase assay was used to detect the target relationship. Oil Red O staining was used to measure the lipid accumulation. HE staining was used for observing pathological feature of liver tissues. High levels of NEAT1 and ROCK1, and low level of miR-146a-5p were identified in NAFLD models. NEAT1 could target miR-146a-5p to promote ROCK1 expression. Knockdown of NEAT1, overexpression of miR-146a-5p and knockdown of ROCK1 inhibited lipid accumulation through activating AMPK pathway. NEAT1 may regulate NAFLD through miR-146a-5p targeting ROCK1, and further affect AMPK/SREBP pathway. This study may provide a new thought for the treatment of NAFLD.
科研通智能强力驱动
Strongly Powered by AbleSci AI